Facebook-f Twitter Tiktok Instagram Youtube
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

Float Short %

2.85

Margin Of Safety %

9

Put/Call OI Ratio

0.86

EPS Next Q Diff

0.03

EPS Last/This Y

0.56

EPS This/Next Y

0.45

Price

68.57

Target Price

100.96

Analyst Recom

1.48

Performance Q

-19.18

Relative Volume

0.87

Beta

1.39

Ticker: DXCM



22 items of 1

DateSymbolLastP/C OIP/C VolTotal OI
2025-03-20DXCM75.090.741.68138940
2025-03-21DXCM73.860.731.08140017
2025-03-24DXCM75.320.790.42112885
2025-03-25DXCM73.560.781.52114281
2025-03-26DXCM72.120.791.33114879
2025-03-27DXCM69.430.802.09115711
2025-03-28DXCM68.340.770.88117646
2025-03-31DXCM68.280.831.11113528
2025-04-01DXCM67.330.821.91115906
2025-04-02DXCM68.090.830.91120841
2025-04-03DXCM61.810.833.50122434
2025-04-04DXCM60.090.833.25125212
2025-04-07DXCM61.590.870.26124293
2025-04-08DXCM60.760.865.73125008
2025-04-09DXCM66.780.880.90127440
2025-04-10DXCM67.370.861.39128995
2025-04-11DXCM66.150.850.42128849
2025-04-14DXCM67.360.860.97126871
2025-04-15DXCM69.240.870.70127747
2025-04-16DXCM68.720.861.06128013
2025-04-17DXCM68.540.860.83128361
2025-04-18DXCM68.570.860.75128361
DateSymbolLastP/C OIP/C VolTotal OI
22 items Current Page1 of 1



22 items of 1

DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
2025-03-20DXCM75.111.999.92.02
2025-03-21DXCM73.881.967.62.02
2025-03-24DXCM75.321.997.52.02
2025-03-25DXCM73.551.961.82.02
2025-03-26DXCM72.131.965.22.02
2025-03-27DXCM69.432.250.62.02
2025-03-28DXCM67.742.260.72.02
2025-03-31DXCM68.262.287.92.02
2025-04-01DXCM67.322.270.22.02
2025-04-02DXCM68.142.291.52.02
2025-04-03DXCM61.752.25.82.02
2025-04-04DXCM59.882.256.52.02
2025-04-07DXCM61.592.2105.52.02
2025-04-08DXCM60.692.269.32.02
2025-04-09DXCM66.792.2163.12.02
2025-04-10DXCM67.312.287.42.02
2025-04-11DXCM66.113.167.42.02
2025-04-14DXCM67.393.197.02.02
2025-04-15DXCM69.233.199.22.02
2025-04-16DXCM68.753.171.62.02
2025-04-17DXCM68.572.675.32.02
2025-04-18DXCM68.572.677.22.02
DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
22 items Current Page1 of 1



22 items of 1

DateTickerInsider TransactionsInstitutional TransactionsFloat Short
2025-03-20DXCM-2.51-1.092.56
2025-03-21DXCM-2.51-1.092.56
2025-03-24DXCM-2.51-1.102.56
2025-03-25DXCM-2.51-1.102.56
2025-03-26DXCM-2.51-1.102.98
2025-03-27DXCM-2.51-1.102.98
2025-03-28DXCM-2.51-1.102.98
2025-03-31DXCM-2.51-1.092.98
2025-04-01DXCM-2.51-1.092.98
2025-04-02DXCM-2.51-1.092.98
2025-04-03DXCM-2.51-1.092.98
2025-04-04DXCM-2.51-1.092.98
2025-04-07DXCM-2.51-1.052.98
2025-04-08DXCM-2.51-1.052.98
2025-04-09DXCM-2.51-1.052.98
2025-04-10DXCM-2.51-1.052.85
2025-04-11DXCM-2.51-1.052.85
2025-04-14DXCM-2.51-1.052.85
2025-04-15DXCM-2.52-1.052.85
2025-04-16DXCM-2.52-1.052.85
2025-04-17DXCM-2.52-1.052.85
2025-04-18DXCM-2.52-1.052.85
DateTickerInsider TransactionsInstitutional TransactionsFloat Short
22 items Current Page1 of 1

Last Quarter Act. EPS​

0.45

Avg. EPS Est. Current Quarter

0.33

Avg. EPS Est. Next Quarter

0.48

Insider Transactions

-2.52

Institutional Transactions

-1.05

Beta

1.39

Average Sales Estimate Current Quarter

1017

Average Sales Estimate Next Quarter

1129

Fair Value

74.88

Quality Score

89

Growth Score

98

Sentiment Score

34

Actual DrawDown %

58.4

Max Drawdown 5-Year %

-63.3

Target Price

100.96

P/E

48.13

Forward P/E

27.71

PEG

2.13

P/S

6.67

P/B

12.74

P/Free Cash Flow

42.63

EPS

1.42

Average EPS Est. Cur. Y​

2.02

EPS Next Y. (Est.)

2.47

Target Price Estimates Raised

Target Price Estimates Lowered

1

Profit Margin

14.29

Relative Volume

0.87

Return on Equity vs Sector %

7.4

Return on Equity vs Industry %

9.2

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

77.2
DexCom, Inc.
Sector: Healthcare
Industry: Medical Devices
Employees: 10200
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for the management of diabetes and metabolic health by patients, caregivers, and clinicians. Its products include Dexcom G6 and Dexcom G7, integrated CGM systems for diabetes management; Dexcom Share, a remote monitoring system; Dexcom Real-Time API, which enables authorized third-party software developers to integrate real-time CGM data into their digital health apps and devices; Dexcom ONE, that is designed to replace finger stick blood glucose testing for diabetes treatment decisions; and Stelo, a new over-the-counter glucose biosensor designed for adults with prediabetes and Type 2 diabetes. The company has a collaboration and license agreement with Verily Life Sciences LLC and Verily Ireland Limited to develop blood-based or interstitial glucose monitoring products. It markets its products directly to endocrinologists, physicians, and diabetes educators. The company was incorporated in 1999 and is headquartered in San Diego, California.
stock quote shares DXCM – DexCom, Inc. Stock Price stock today
news today DXCM – DexCom, Inc. stock forecast ,stock prediction 2023 2024 2025
marketwatch DXCM – DexCom, Inc. yahoo finance google finance
stock history DXCM – DexCom, Inc. invest stock market
stock prices DXCM premarket after hours
ticker DXCM fair value insiders trading

Investment involves risk. As a general rule, you should only trade in financial products that you are familiar with and understand the risk associated with them. The risk warning described in each financial product below is not exhaustive, you should carefully consider your investment experience, financial situation, investment objective, risk tolerance level and consult your independent financial adviser as to the suitability of your situation prior making any investment.

Facebook-f Twitter Tiktok Instagram Youtube

Get Started

About